Literature DB >> 8175159

A proposed system for the nomenclature of hepatitis C viral genotypes.

P Simmonds, A Alberti, H J Alter, F Bonino, D W Bradley, C Brechot, J T Brouwer, S W Chan, K Chayama, D S Chen.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8175159

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  149 in total

Review 1.  Hepatitis C in childhood.

Authors:  F Bortolotti
Journal:  Indian J Pediatr       Date:  1995 Sep-Oct       Impact factor: 1.967

2.  Hepatitis C virus serotypes and sources of infection in patients with HCV-related chronic liver disease from one geographical area in southeast Italy.

Authors:  P Dentico; N Curatolo; R Sacco; M De Luca; A Volpe; C Ranieri; C Genchi; L Petracca; R Buongiorno
Journal:  Infection       Date:  1999 Mar-Apr       Impact factor: 3.553

Review 3.  Autoimmunity in liver diseases.

Authors:  C P Strassburg; P Obermayer-Straub; M P Manns
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

4.  Interferon inhibits progression of liver fibrosis and reduces the risk of hepatocarcinogenesis in patients with chronic hepatitis C: a retrospective multicenter analysis of 652 patients.

Authors:  Mitsuhiro Takimoto; Shogo Ohkoshi; Takafumi Ichida; Yasuo Takeda; Minoru Nomoto; Hitoshi Asakura; Akira Naito; Shigeki Mori; Kojiro Hata; Kentaro Igarashi; Hidenori Hara; Hironobu Ohta; Kenji Soga; Toshiaki Watanabe; Tomoteru Kamimura
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

5.  Distribution of HCV genotypes among risk groups in Serbia.

Authors:  G Stamenkovic; S Zerjav; Z M Velickovic; K Krtolica; V L Samardzija; L Jemuovic; D Nozic; B Dimitrijevic
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

6.  Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome.

Authors:  T Gayowski; N Singh; I R Marino; H Vargas; M Wagener; C Wannstedt; F Morelli; T Laskus; J J Fung; J Rakela; T E Starzl
Journal:  Transplantation       Date:  1997-08-15       Impact factor: 4.939

7.  Prevalence of hepatitis C virus infection in Nanjing, southern China.

Authors:  K Suzuki; M Mizokami; K Cao; X S Wu; R R Wu; A Hata; M Sasaki; Z X Fang; L Y Zhang; J Y Lau; S Iino
Journal:  Eur J Epidemiol       Date:  1997-07       Impact factor: 8.082

8.  Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein.

Authors:  Ania Owsianka; Alexander W Tarr; Vicky S Juttla; Dimitri Lavillette; Birke Bartosch; François-Loïc Cosset; Jonathan K Ball; Arvind H Patel
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Influence of hepatitis C virus (HCV) genotypes on HCV recombinant immunoblot assay patterns.

Authors:  J M Pawlotsky; F Roudot-Thoraval; C Pellet; P Aumont; F Darthuy; J Remire; J Duval; D Dhumeaux
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

10.  Long-term persistence of infection in chimpanzees inoculated with an infectious hepatitis C virus clone is associated with a decrease in the viral amino acid substitution rate and low levels of heterogeneity.

Authors:  Javier Fernandez; Deborah Taylor; Duncan R Morhardt; Kathleen Mihalik; Montserrat Puig; Charles M Rice; Stephen M Feinstone; Marian E Major
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.